A detailed history of Caitong International Asset Management Co., LTD transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 22,776 shares of PACB stock, worth $36,669. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,776
Previous 2,298 891.12%
Holding current value
$36,669
Previous $2.85 Million 922.91%
% of portfolio
0.02%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$1.17 - $1.69 $23,959 - $34,607
20,478 Added 891.12%
22,776 $29.2 Million
Q2 2025

Jul 31, 2025

SELL
$0.91 - $1.45 $13,104 - $20,881
-14,401 Reduced 86.24%
2,298 $2.85 Million
Q1 2025

May 13, 2025

BUY
$1.14 - $2.1 $19,036 - $35,067
16,699 New
16,699 $19.7 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $362M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.